Package 63759-3032-1

Brand: bortezomib

Generic: bortezomib
NDC Package

Package Facts

Identity

Package NDC 63759-3032-1
Digits Only 6375930321
Product NDC 63759-3032
Product ID 63759-3032_71ebcbb5-31e2-4394-8a38-d833fd3c733a
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (63759-3032-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-09-25
Brand bortezomib
Generic bortezomib
Sample Package No

Linked Drug Pages (1)

Bortezomib ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "71ebcbb5-31e2-4394-8a38-d833fd3c733a", "openfda": {"nui": ["N0000175604", "N0000175075"], "upc": ["0363759303212"], "unii": ["69G8BD63PP"], "rxcui": ["2608948"], "spl_set_id": ["61539d49-dc21-4576-8813-4bc8abf3868c"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Shilpa Medicare Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63759-3032-1)  / 1.4 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63759-3032-1", "marketing_start_date": "20240925"}], "brand_name": "Bortezomib", "product_id": "63759-3032_71ebcbb5-31e2-4394-8a38-d833fd3c733a", "dosage_form": "INJECTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "63759-3032", "generic_name": "Bortezomib", "labeler_name": "Shilpa Medicare Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bortezomib", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1.4mL"}], "application_number": "NDA212782", "marketing_category": "NDA", "marketing_start_date": "20240925", "listing_expiration_date": "20261231"}